Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse.
D000818:Animals; D001555:Benzene Derivatives; D001665:Binding Sites; D002219:Carbamates; D055598:Chemical Phenomena; D002621:Chemistry; D002713:Chlorine; D003864:Depression, Chemical; D005459:Fluorides; D005493:Folic Acid Antagonists; D007422:Intestines / Q000201:enzymology*; D007939:Leukemia L1210 / Q000188:drug therapy / Q000201:enzymology* / Q000401:mortality; D008099:Liver / Q000201:enzymology*; D051379:Mice; D011743:Pyrimidines / Q000627:therapeutic use; D013154:Spleen / Q000201:enzymology*; D013451:Sulfonic Acids / Q000627:therapeutic use; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism; D013997:Time Factors; D014227:Triazines / Q000627:therapeutic use
D001555:Benzene Derivatives; D002219:Carbamates; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013451:Sulfonic Acids; D014227:Triazines; D002713:Chlorine; D013762:Tetrahydrofolate Dehydrogenase; D005459:Fluorides